Mice lacking alpha-synuclein are resistant to mitochondrial toxins
Abnormalities in the function of α-synuclein are implicated in the pathogenesis of Parkinson's disease (PD). We found that α-synuclein-deficient mice are resistant to MPTP-induced degeneration of dopaminergic neurons. There was dose-dependent protection against loss of both dopamine in the stri...
Main Authors: | , , , , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2006-03-01
|
Series: | Neurobiology of Disease |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S0969996105002421 |
id |
doaj-614396f73bb445cbb6513e67f25816df |
---|---|
record_format |
Article |
spelling |
doaj-614396f73bb445cbb6513e67f25816df2021-03-20T04:52:00ZengElsevierNeurobiology of Disease1095-953X2006-03-01213541548Mice lacking alpha-synuclein are resistant to mitochondrial toxinsPeter Klivenyi0Donald Siwek1Gabrielle Gardian2Lichuan Yang3Anatoly Starkov4Carine Cleren5Robert J. Ferrante6Neil W. Kowall7Asa Abeliovich8M. Flint Beal9Department of Neurology and Neuroscience, Weill Medical College of Cornell University, New York-Presbyterian Hospital, 525 East 68th Street, New York, NY 10021, USAGeriatric Research Education and Clinical Center, Bedford VA Medical Center, Bedford, MA and Neurology, Pathology, and Psychiatry Departments, Boston University School of Medicine, Boston, MA 02118, USADepartment of Neurology and Neuroscience, Weill Medical College of Cornell University, New York-Presbyterian Hospital, 525 East 68th Street, New York, NY 10021, USADepartment of Neurology and Neuroscience, Weill Medical College of Cornell University, New York-Presbyterian Hospital, 525 East 68th Street, New York, NY 10021, USADepartment of Neurology and Neuroscience, Weill Medical College of Cornell University, New York-Presbyterian Hospital, 525 East 68th Street, New York, NY 10021, USADepartment of Neurology and Neuroscience, Weill Medical College of Cornell University, New York-Presbyterian Hospital, 525 East 68th Street, New York, NY 10021, USAGeriatric Research Education and Clinical Center, Bedford VA Medical Center, Bedford, MA and Neurology, Pathology, and Psychiatry Departments, Boston University School of Medicine, Boston, MA 02118, USAGeriatric Research Education and Clinical Center, Bedford VA Medical Center, Bedford, MA and Neurology, Pathology, and Psychiatry Departments, Boston University School of Medicine, Boston, MA 02118, USADepartment of Neurology, College of Physicians and Surgeons, Columbia University, New York -Presbyterian Hospital, New York, NY 10021, USADepartment of Neurology and Neuroscience, Weill Medical College of Cornell University, New York-Presbyterian Hospital, 525 East 68th Street, New York, NY 10021, USA; Corresponding author. Fax: +1 212 746 8532.Abnormalities in the function of α-synuclein are implicated in the pathogenesis of Parkinson's disease (PD). We found that α-synuclein-deficient mice are resistant to MPTP-induced degeneration of dopaminergic neurons. There was dose-dependent protection against loss of both dopamine in the striatum and dopamine transporter (DAT) immunoreactive neurons in the substantia nigra. These effects were not due to alterations in MPTP processing. We found that α-synuclein-deficient mice are also resistant to both malonate and 3-nitropropionic acid (3-NP) neurotoxicity. There was reduced generation of reactive oxygen species in α-synuclein-deficient mice following administration of 3-NP. These findings implicate α-synuclein as a modulator of oxidative damage, which has been implicated in neuronal death produced by MPTP and other mitochondrial toxins.http://www.sciencedirect.com/science/article/pii/S0969996105002421MPTPParaquat3-Nitropropionic acidMalonateMPP+MPP+ levels |
collection |
DOAJ |
language |
English |
format |
Article |
sources |
DOAJ |
author |
Peter Klivenyi Donald Siwek Gabrielle Gardian Lichuan Yang Anatoly Starkov Carine Cleren Robert J. Ferrante Neil W. Kowall Asa Abeliovich M. Flint Beal |
spellingShingle |
Peter Klivenyi Donald Siwek Gabrielle Gardian Lichuan Yang Anatoly Starkov Carine Cleren Robert J. Ferrante Neil W. Kowall Asa Abeliovich M. Flint Beal Mice lacking alpha-synuclein are resistant to mitochondrial toxins Neurobiology of Disease MPTP Paraquat 3-Nitropropionic acid Malonate MPP+ MPP+ levels |
author_facet |
Peter Klivenyi Donald Siwek Gabrielle Gardian Lichuan Yang Anatoly Starkov Carine Cleren Robert J. Ferrante Neil W. Kowall Asa Abeliovich M. Flint Beal |
author_sort |
Peter Klivenyi |
title |
Mice lacking alpha-synuclein are resistant to mitochondrial toxins |
title_short |
Mice lacking alpha-synuclein are resistant to mitochondrial toxins |
title_full |
Mice lacking alpha-synuclein are resistant to mitochondrial toxins |
title_fullStr |
Mice lacking alpha-synuclein are resistant to mitochondrial toxins |
title_full_unstemmed |
Mice lacking alpha-synuclein are resistant to mitochondrial toxins |
title_sort |
mice lacking alpha-synuclein are resistant to mitochondrial toxins |
publisher |
Elsevier |
series |
Neurobiology of Disease |
issn |
1095-953X |
publishDate |
2006-03-01 |
description |
Abnormalities in the function of α-synuclein are implicated in the pathogenesis of Parkinson's disease (PD). We found that α-synuclein-deficient mice are resistant to MPTP-induced degeneration of dopaminergic neurons. There was dose-dependent protection against loss of both dopamine in the striatum and dopamine transporter (DAT) immunoreactive neurons in the substantia nigra. These effects were not due to alterations in MPTP processing. We found that α-synuclein-deficient mice are also resistant to both malonate and 3-nitropropionic acid (3-NP) neurotoxicity. There was reduced generation of reactive oxygen species in α-synuclein-deficient mice following administration of 3-NP. These findings implicate α-synuclein as a modulator of oxidative damage, which has been implicated in neuronal death produced by MPTP and other mitochondrial toxins. |
topic |
MPTP Paraquat 3-Nitropropionic acid Malonate MPP+ MPP+ levels |
url |
http://www.sciencedirect.com/science/article/pii/S0969996105002421 |
work_keys_str_mv |
AT peterklivenyi micelackingalphasynucleinareresistanttomitochondrialtoxins AT donaldsiwek micelackingalphasynucleinareresistanttomitochondrialtoxins AT gabriellegardian micelackingalphasynucleinareresistanttomitochondrialtoxins AT lichuanyang micelackingalphasynucleinareresistanttomitochondrialtoxins AT anatolystarkov micelackingalphasynucleinareresistanttomitochondrialtoxins AT carinecleren micelackingalphasynucleinareresistanttomitochondrialtoxins AT robertjferrante micelackingalphasynucleinareresistanttomitochondrialtoxins AT neilwkowall micelackingalphasynucleinareresistanttomitochondrialtoxins AT asaabeliovich micelackingalphasynucleinareresistanttomitochondrialtoxins AT mflintbeal micelackingalphasynucleinareresistanttomitochondrialtoxins |
_version_ |
1724211910113492992 |